BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 25142629)

  • 1. Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
    Creasman WT; Ali S; Mutch DG; Zaino RJ; Powell MA; Mannel RS; Backes FJ; DiSilvestro PA; Argenta PA; Pearl ML; Lele SB; Guntupalli SR; Waggoner S; Spirtos N; Boggess JF; Edwards RP; Filiaci VL; Miller DS
    Gynecol Oncol; 2017 Jun; 145(3):519-525. PubMed ID: 28392124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study.
    Shim SH; Lim J; Kim JH; Lee YJ; Ha HI; Lim MC; Won YJ
    J Gynecol Oncol; 2024 May; 35(3):e32. PubMed ID: 38130136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients with late recurrence endometrial cancer.
    Çakır İ; Gülseren V; Özdemir İA; Abacı H; Talu ECK; Çakır ZE; Ata C; Kuru O; Gökçü M; Sancı M; Güngördük K
    J Cancer Res Ther; 2024 Jan; 20(1):232-237. PubMed ID: 38554326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature.
    Jensen GL; Mezera MA; Hasan S; Hammonds KP; Swanson GP; El-Ghamry MN
    Radiat Oncol J; 2021 Sep; 39(3):219-230. PubMed ID: 34610661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment.
    Aloisi A; Casanova JM; Tseng JH; Seader KA; Nguyen NT; Alektiar KM; Makker V; Chiang S; Soslow RA; Leitao MM; Abu-Rustum NR
    Gynecol Oncol; 2018 Dec; 151(3):395-400. PubMed ID: 30286945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research into the Value of B-Mode Ultrasound, CT and MRI Examinations in the Diagnosis of Preoperative Myometrial Infiltration of Endometrial Cancer and Lymph Node Metastasis.
    Lu R; Guixia S
    Open Med (Wars); 2015; 10(1):388-393. PubMed ID: 28352724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?
    Koskas M; Rouzier R; Amant F
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):845-57. PubMed ID: 25817745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent.
    Rajasooriyar C; Bernshaw D; Kondalsamy-Chennakesavan S; Mileshkin L; Narayan K
    J Gynecol Oncol; 2014 Oct; 25(4):313-9. PubMed ID: 25142629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
    Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA
    Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal metastasis in endometrial cancer.
    Willis G; Misas JE; Byrne W; Podczaski E
    Eur J Gynaecol Oncol; 2011; 32(3):259-63. PubMed ID: 21797112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
    Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer.
    Secord AA; Geller MA; Broadwater G; Holloway R; Shuler K; Dao NY; Gehrig PA; O'Malley DM; Finkler N; Havrilesky LJ
    Gynecol Oncol; 2013 Jan; 128(1):65-70. PubMed ID: 23085460
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.